MDL

Lanier Law Firm's Rebecca Phillips Named to Leadership Post in Bard PowerPort MDL

Retrieved on: 
Tuesday, October 3, 2023
Bard, IBM 308X, Infection, Embolism, Medicine, MDL, Port (medical), District court, Patient, Physician, Pelvic floor dysfunction, Johnson & Johnson, Thrombus, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Douglas v. U.S. District Court ex rel Talk America, Food, Injury, Medical device, Pharmaceutical industry, Pinnacle

HOUSTON, Oct. 3, 2023 /PRNewswire/ -- Rebecca Phillips of The Lanier Law Firm has been appointed among three co-lead counsels for plaintiffs in the multidistrict litigation alleging complications and injuries from Bard PowerPort implantable catheter devices.

Key Points: 
  • HOUSTON, Oct. 3, 2023 /PRNewswire/ -- Rebecca Phillips of The Lanier Law Firm has been appointed among three co-lead counsels for plaintiffs in the multidistrict litigation alleging complications and injuries from Bard PowerPort implantable catheter devices.
  • The Bard devices are designed to provide intravenous delivery of fluids or medicine and was initially approved by the U.S. Food and Drug Administration in 2000.
  • In March 2020, the FDA posted a recall notice for several Bard PowerPort models due to increased device failure rates.
  • The case is IN RE: Bard Implanted Port Catheter Product Liability Litigation, MDL 3081, in U.S. District Court for the District of Arizona.

BERGER MONTAGUE SHAREHOLDER SHANON J. CARSON AND SENIOR COUNSEL JENNIFER P. ELWELL APPOINTED TO LEADERSHIP POSITIONS IN THE BARD IMPLANTED PORT CATHETER MDL LITIGATION

Retrieved on: 
Tuesday, September 26, 2023
Infection, Thrombosis, Bard, Arrhythmia, Telephone, Medicine, Plaintiff, Fungus, Sale, MDL Information Systems, Sepsis, MDL, Amputation, District court, Bleeding, Collection, Bard (company), Risk, BD (company), Fracture, Pelvic floor dysfunction, Death, Douglas v. U.S. District Court ex rel Talk America, Barium sulfate, Skin, Injury, Medical device

The court appointed Mr. Carson to the Plaintiffs' Executive Committee and Ms. Elwell to the Plaintiffs' Steering Committee.

Key Points: 
  • The court appointed Mr. Carson to the Plaintiffs' Executive Committee and Ms. Elwell to the Plaintiffs' Steering Committee.
  • Berger Montague has been contacted by hundreds of individuals alleging injuries by Bard port catheters.
  • Bard port catheters are surgically placed under the skin, typically in the chest, and consist of an injection port and a catheter.
  • Please direct all inquiries to Berger Montague's Bard Port Catheter Litigation Team by email to [email protected] or by telephone at (215) 875-3072.

The Village of Farmingdale Benefits from the 3M and DuPont, Chemours and Corteva Landmark Settlements in the AFFF MDL

Retrieved on: 
Thursday, September 14, 2023
Professional Services, Environment, Utilities, Legal, Environmental Health, Energy, Foam, AFFF, PFAS, Table, Aqueous solution, Multidistrict litigation, MDL, GxP, Health, Counsel, Insurance, Corteva, Trustee, Chemours

The Village of Farmingdale is pleased to announce its satisfaction with the groundbreaking settlements reached in the Aqueous Film-Forming Foam (AFFF) Multi-District Litigation (MDL) involving 3M, DuPont, Chemours, and Corteva.

Key Points: 
  • The Village of Farmingdale is pleased to announce its satisfaction with the groundbreaking settlements reached in the Aqueous Film-Forming Foam (AFFF) Multi-District Litigation (MDL) involving 3M, DuPont, Chemours, and Corteva.
  • As per the Estimated Allocation Range Tables provided by the PFAS Settlement Steering Committee, the Village of Farmingdale anticipates receiving substantial compensation from these settlements.
  • Initial settlement amounts are anticipated to provide the Village of Farmingdale of up to $5,000,000.00 from DuPont, Chemours and Corteva and 3M.
  • Notably, there are 15 defendants remaining in additional litigation and the Village is working to secure additional settlements from those defendants.

Lex Machina Releases 2023 Product Liability Litigation Report

Retrieved on: 
Thursday, September 14, 2023
Research, Lex Machina, Ford Motor Company, Syngenta, Kirkland & Ellis, Crowell, Nelson Mullins Riley & Scarborough, MDL, Punitive damages, Partner, LexisNexis, Johnson & Johnson, Software, Insurance

MENLO PARK, Calif., Sept. 14, 2023 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Product Liability Litigation Report. The report examines trends in product liability litigation in federal district courts and appellate courts. Focusing on the five-year period from 2018 to 2022, it surveys emerging trends in case filings, venues, judges, law firms, parties, timing metrics, case resolutions, findings, and damages. The report often focuses on different sets of data, e.g., filtering cases in order to provide analytics on general product liability cases, medical device/pharmaceutical cases, vehicle cases, and federal appellate product liability cases.

Key Points: 
  • Product liability cases (excluding MDL Associated Cases) have generally increased over recent years, with subsets of cases clustered around specific large-scale litigation events
    MENLO PARK, Calif., Sept. 14, 2023 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Product Liability Litigation Report.
  • The report examines trends in product liability litigation in federal district courts and appellate courts.
  • The report often focuses on different sets of data, e.g., filtering cases in order to provide analytics on general product liability cases, medical device/pharmaceutical cases, vehicle cases, and federal appellate product liability cases.
  • "Lex Machina monitors different trends in product liability litigation through analyzing the kinds of data offered in this report," said Ron Porter, Lex Machina's product liability legal data expert and editor of the report.

Leading Commercial Litigation Partner Susan Shin Joins Hunton Andrews Kurth in New York

Retrieved on: 
Monday, September 11, 2023
LLP, Health, Arnold & Porter, Daniel Inouye, Chambers, Policy, Shin, The American Lawyer, RMBS, Multidistrict litigation, RICO, Lawyer, Publication, Rutgers University, MDL, Weil, Gotshal & Manges, District court, Chambers and Partners, Supreme court, The National Law Journal, Arnold, American Bar Association, Hague Convention, Columbia Law School, Tobacco, Real estate, Insurance

New York, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Susan L. Shin , a highly regarded and nationally recognized complex commercial litigation and trial attorney, has joined Hunton Andrews Kurth LLP as a partner in New York.

Key Points: 
  • New York, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Susan L. Shin , a highly regarded and nationally recognized complex commercial litigation and trial attorney, has joined Hunton Andrews Kurth LLP as a partner in New York.
  • Shin joins Hunton Andrews Kurth from Weil, Gotshal & Manges, LLP, where she was a partner in the complex litigation practice.
  • Since our founding in 1901, Hunton Andrews Kurth has been a business-focused firm, an approach that we bring to today’s litigation climate.
  • With lawyers in the United States, Asia, Europe and the Middle East, Hunton Andrews Kurth LLP serves clients across a broad range of complex transactional, litigation and regulatory matters.

Philips reaches resolution of US economic loss litigation

Retrieved on: 
Thursday, September 7, 2023
Respironics, Dubrovka, Dubrovsky Settlement Administrative Okrug, Dubrovsky District, Bryansk Oblast, Sleep, MDL, United States district court, EUR, Hospital, Philips, Patient, AEX, Court, PHG, NYSE, Tobacco, Pharmaceutical industry

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the company and certain of its US subsidiaries, including Philips Respironics, have reached an agreement to resolve all economic loss claims in the US Multidistrict Litigation (MDL) related to Philips Respironics’ voluntary recall of certain sleep and respiratory care devices.

Key Points: 
  • Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the company and certain of its US subsidiaries, including Philips Respironics, have reached an agreement to resolve all economic loss claims in the US Multidistrict Litigation (MDL) related to Philips Respironics’ voluntary recall of certain sleep and respiratory care devices.
  • Philips Respironics has recorded a provision for an amount of EUR 575 million in the first quarter of 2023 to cover for the estimated costs of the final settlement.
  • The agreement does not settle any personal injury or medical monitoring claims in the MDL, which the Philips parties have moved to dismiss.
  • • All related inquiries by patients, hospitals and sleep labs in the US should be directed to the third-party Settlement Administrator, Angeion Group.

Baron & Budd Announces $1.4 Billion Settlement From Kroger in Nationwide Opioid Lawsuit

Retrieved on: 
Saturday, September 9, 2023
Class Action Lawsuit, Professional Services, Legal, Kroger, Russell Budd, Baron & Budd, P.C., Pharmacy, NAS, Opioid use disorder, AG, Prescription, OUD, Negotiation, Heroin, Opioid, MDL, Alcohol withdrawal syndrome, Drug, Patient safety, Child, City, Baron, Cereal, State

Today, the nationally recognized attorneys at Baron & Budd announced a $1.4 billion nationwide settlement agreement with retail pharmacy giant Kroger concerning the company’s role in the opioid epidemic.

Key Points: 
  • Today, the nationally recognized attorneys at Baron & Budd announced a $1.4 billion nationwide settlement agreement with retail pharmacy giant Kroger concerning the company’s role in the opioid epidemic.
  • Baron & Budd’s President and Managing Shareholder, Russell Budd, played a lead role in negotiating the settlement.
  • When added to the previous settlements obtained from opioids manufacturers, distributors, and pharmacies, this $1.4 billion settlement with Kroger brings the total national settlement value to nearly $61.4 billion.
  • While Kroger is typically known as a grocery store, the company has more than 2,000 pharmacies within its stores nationwide.

McCune Law Group Secures Settlement in "Largest MDL in US History" Against 3M--$6 Billion

Retrieved on: 
Tuesday, September 12, 2023
Federal Aviation Administration Records Center, Certificate, Hearing loss, Tinnitus, MLG, 2017–2018 Department of Justice metadata seizures, DOJ, Immunity, Veteran, Government, MDL, Documentation, Comment, Pleasure, Court, APC, Roger Hawkins (drummer), DD214, Pharmaceutical industry

ONTARIO, Calif., Sept. 12, 2023 /PRNewswire/ -- McCune Law Group, APC, (MLG), in concert with attorneys and law firms from around the country in the largest multi-district litigation (MDL) in United States history , has successfully secured a settlement from multi-national corporate giant 3M .

Key Points: 
  • ONTARIO, Calif., Sept. 12, 2023 /PRNewswire/ -- McCune Law Group, APC, (MLG), in concert with attorneys and law firms from around the country in the largest multi-district litigation (MDL) in United States history , has successfully secured a settlement from multi-national corporate giant 3M .
  • MLG Attorney Michele Vercoski represented hundreds of military service members and veterans in this matter over the past five years.
  • Failure to provide documentation quickly could result in delayed settlement funds or refusal from the Court to issue any funds at all.
  • To arrange comment from Michele Vercoski, please contact the MLG Public Relations department at [email protected] .

Lyons & Simmons Earns Fourth Consecutive Selection Among Top Personal Injury Firms

Retrieved on: 
Tuesday, September 5, 2023
The National Law Journal, LLP, MDL, ETL, Lawyer, The American Lawyer, Courtroom View Network, Personal injury, Frank Andrews (Texas lawyer), Tobacco

DALLAS, Sept. 5, 2023 /PRNewswire/ -- For a fourth consecutive year, Lyons & Simmons, LLP's focus on results has earned the trial firm a place among the top personal injury law firms in Dallas by readers of Texas Lawyer magazine.

Key Points: 
  • DALLAS, Sept. 5, 2023 /PRNewswire/ -- For a fourth consecutive year, Lyons & Simmons, LLP 's focus on results has earned the trial firm a place among the top personal injury law firms in Dallas by readers of Texas Lawyer magazine.
  • Lyons & Simmons is the only Dallas firm to be voted into the top three each year since the magazine added the personal injury designation to its annual "Best Of" survey in 2020.
  • Based on its repeat recognition, the firm earned a place in the Texas Lawyer "Best Of" Hall of Fame in 2022.
  • With a focus on large, complex personal injury and wrongful death cases, Lyons & Simmons has a reputation for record jury verdicts and settlements.

Transportation Security Administration seeks comments on proposed regulation regarding mobile driver's licenses and REAL ID-compliant identification

Retrieved on: 
Wednesday, August 30, 2023
REAL, String interpolation, Notice of proposed rulemaking, Airport, Transport, Smartphone, Transportation Security Administration, TSA, ID, Baggage, Mobile phone, MDL

WASHINGTON, Aug. 30, 2023 /PRNewswire/ -- The Transportation Security Administration (TSA) published a Notice of Proposed Rulemaking that would allow the continued use of mobile driver's licenses (mDL) at TSA airport security checkpoints beyond the 2025 REAL ID implementation deadline.

Key Points: 
  • WASHINGTON, Aug. 30, 2023 /PRNewswire/ -- The Transportation Security Administration (TSA) published a Notice of Proposed Rulemaking that would allow the continued use of mobile driver's licenses (mDL) at TSA airport security checkpoints beyond the 2025 REAL ID implementation deadline.
  • This proposed rule would allow for continued use of mDLs at participating TSA checkpoints after May 7, 2025, when passengers will be required to show REAL ID-compliant identification.
  • "TSA fully supports the integration of digital identity technology, including mobile driver's licenses, as part of our transportation security framework," said TSA Administrator David Pekoske.
  • "This incremental approach balances security and passenger experience, encourages digital identity innovation and investment and ensures that we honor the intent of the REAL ID Act.